DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+14.16%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$277M
AUM Growth
+$277M
(-2.8%)
Cap. Flow
-$6.89M
Cap. Flow
% of AUM
-2.49%
Top 10 Holdings %
Top 10 Hldgs %
77.48%
Holding
98
New
6
Increased
9
Reduced
11
Closed
9
Top Buys
| 1 |
Janus Henderson AAA CLO ETF
JAAA
|
$25.6M |
| 2 |
Collegium Pharmaceutical
COLL
|
$943K |
| 3 |
Pfizer
PFE
|
$796K |
| 4 |
ATYR
aTyr Pharma
ATYR
|
$727K |
| 5 |
Medtronic
MDT
|
$639K |
Top Sells
| 1 |
Calumet Specialty Products
CLMT
|
$14.8M |
| 2 |
Panagram BBB-B CLO ETF
CLOZ
|
$13.3M |
| 3 |
GSK
GSK
|
$2.66M |
| 4 |
Digimarc
DMRC
|
$2.25M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$1.85M |
Sector Composition
| 1 | Materials | 29.62% |
| 2 | Healthcare | 26.23% |
| 3 | Financials | 16.88% |
| 4 | Communication Services | 7.75% |
| 5 | Industrials | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ryman Hospitality Properties
RHP
$6.22B
| $1.25M | 0.45% |
12,000
| – | – |
|
|
MREO
27
Mereo BioPharma
MREO
$272M
| $1.16M | 0.42% |
331,000
| – | – |
|
|
ATYR
28
aTyr Pharma
ATYR
$527M
| $1.12M | 0.4% |
308,133
+200,959
| +188% | +$727K |
|
|
29
Collegium Pharmaceutical
COLL
$1.22B
| $943K | 0.34% |
+32,927
| New | +$943K |
|
30
SPDR S&P Biotech ETF
XBI
$5.07B
| $901K | 0.33% |
10,000
| – | – |
|
31
AbbVie
ABBV
$372B
| $895K | 0.32% |
5,037
| – | – |
|
32
Xenon Pharmaceuticals
XENE
$2.98B
| $818K | 0.3% |
20,866
| – | – |
|
33
Vertex Pharmaceuticals
VRTX
$100B
| $805K | 0.29% |
2,000
| – | – |
|
34
Kimberly-Clark
KMB
$42.8B
| $786K | 0.28% |
6,000
| – | – |
|
35
DuPont de Nemours
DD
$32.2B
| $757K | 0.27% |
9,930
| – | – |
|
36
Microsoft
MSFT
$3.77T
| $674K | 0.24% |
1,600
| – | – |
|
37
Corteva
CTVA
$50.4B
| $659K | 0.24% |
11,563
| – | – |
|
|
38
Medtronic
MDT
$119B
| $639K | 0.23% |
+8,000
| New | +$639K |
|
39
Evolus
EOLS
$494M
| $636K | 0.23% |
57,570
| – | – |
|
40
Apple
AAPL
$3.45T
| $625K | 0.23% |
2,494
| – | – |
|
41
MeiraGTx Holdings
MGTX
$587M
| $579K | 0.21% |
95,080
+90,377
| +1,922% | +$550K |
|
42
Mondelez International
MDLZ
$79.5B
| $538K | 0.19% |
9,000
| – | – |
|
|
CYBN
43
Cybin
CYBN
$176M
| $533K | 0.19% |
+60,446
| New | +$533K |
|
44
Canadian Natural Resources
CNQ
$65.9B
| $519K | 0.19% |
16,800
| – | – |
|
45
Xoma
XOMA
$392M
| $518K | 0.19% |
19,722
| – | – |
|
46
Viridian Therapeutics
VRDN
$1.5B
| $479K | 0.17% |
+25,000
| New | +$479K |
|
47
IBM
IBM
$227B
| $471K | 0.17% |
2,142
| – | – |
|
|
48
BioMarin Pharmaceuticals
BMRN
$11.2B
| $381K | 0.14% |
5,800
-28,200
| -83% | -$1.85M |
|
49
Eli Lilly
LLY
$657B
| $232K | 0.08% |
300
| – | – |
|
50
NVIDIA
NVDA
$4.24T
| $172K | 0.06% |
1,280
| – | – |
|